ABBVIE INC (1ABBV.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1ABBV - US00287Y1091 - Common Stock
194.2 EUR
-8.8 (-4.33%)
Overall 1ABBV gets a fundamental rating of 5 out of 10. We evaluated 1ABBV against 81 industry peers in the Biotechnology industry. 1ABBV has a medium profitability rating, but doesn't score so well on its financial health evaluation. 1ABBV has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year 1ABBV was profitable.
1ABBV had a positive operating cash flow in the past year.
1ABBV had positive earnings in each of the past 5 years.
In the past 5 years 1ABBV always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of 1ABBV (1.75%) is better than 73.49% of its industry peers.
1ABBV's Return On Invested Capital of 15.64% is amongst the best of the industry. 1ABBV outperforms 90.36% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 1ABBV is in line with the industry average of 11.80%.
The 3 year average ROIC (13.67%) for 1ABBV is below the current ROIC(15.64%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.75% | ||
| ROE | N/A | ||
| ROIC | 15.64% |
ROA(3y)5.07%
ROA(5y)5.21%
ROE(3y)80.76%
ROE(5y)70.31%
ROIC(3y)13.67%
ROIC(5y)12.68%
1.3 Margins
1ABBV has a better Profit Margin (3.94%) than 77.11% of its industry peers.
In the last couple of years the Profit Margin of 1ABBV has declined.
Looking at the Operating Margin, with a value of 33.05%, 1ABBV belongs to the top of the industry, outperforming 85.54% of the companies in the same industry.
1ABBV's Operating Margin has declined in the last couple of years.
1ABBV has a Gross Margin of 71.16%. This is comparable to the rest of the industry: 1ABBV outperforms 59.04% of its industry peers.
In the last couple of years the Gross Margin of 1ABBV has declined.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 33.05% | ||
| PM (TTM) | 3.94% | ||
| GM | 71.16% |
OM growth 3Y-5.46%
OM growth 5Y-6.52%
PM growth 3Y-28.3%
PM growth 5Y-20.42%
GM growth 3Y0.39%
GM growth 5Y-1.92%
2. Health
2.1 Basic Checks
1ABBV has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
The number of shares outstanding for 1ABBV remains at a similar level compared to 1 year ago.
1ABBV has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, 1ABBV has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.45 indicates that 1ABBV is not a great score, but indicates only limited risk for bankruptcy at the moment.
1ABBV has a Altman-Z score of 2.45. This is in the better half of the industry: 1ABBV outperforms 71.08% of its industry peers.
The Debt to FCF ratio of 1ABBV is 3.49, which is a good value as it means it would take 1ABBV, 3.49 years of fcf income to pay off all of its debts.
1ABBV has a Debt to FCF ratio of 3.49. This is in the better half of the industry: 1ABBV outperforms 78.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 3.49 | ||
| Altman-Z | 2.45 |
ROIC/WACC1.88
WACC8.33%
2.3 Liquidity
1ABBV has a Current Ratio of 0.72. This is a bad value and indicates that 1ABBV is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of 1ABBV (0.72) is worse than 79.52% of its industry peers.
A Quick Ratio of 0.60 indicates that 1ABBV may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.60, 1ABBV is doing worse than 80.72% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.72 | ||
| Quick Ratio | 0.6 |
3. Growth
3.1 Past
1ABBV shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -12.09%.
Measured over the past 5 years, 1ABBV shows a small growth in Earnings Per Share. The EPS has been growing by 2.51% on average per year.
1ABBV shows a small growth in Revenue. In the last year, the Revenue has grown by 7.40%.
Measured over the past years, 1ABBV shows a quite strong growth in Revenue. The Revenue has been growing by 11.11% on average per year.
EPS 1Y (TTM)-12.09%
EPS 3Y-7.24%
EPS 5Y2.51%
EPS Q2Q%-38%
Revenue 1Y (TTM)7.4%
Revenue growth 3Y0.08%
Revenue growth 5Y11.11%
Sales Q2Q%9.1%
3.2 Future
Based on estimates for the next years, 1ABBV will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.69% on average per year.
1ABBV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.42% yearly.
EPS Next Y7.28%
EPS Next 2Y19.81%
EPS Next 3Y16.75%
EPS Next 5Y13.69%
Revenue Next Year8.73%
Revenue Next 2Y9.07%
Revenue Next 3Y8.57%
Revenue Next 5Y7.42%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 24.09, which indicates a rather expensive current valuation of 1ABBV.
Based on the Price/Earnings ratio, 1ABBV is valued a bit cheaper than the industry average as 77.11% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 26.84, 1ABBV is valued at the same level.
With a Price/Forward Earnings ratio of 15.68, 1ABBV is valued correctly.
Based on the Price/Forward Earnings ratio, 1ABBV is valued cheaply inside the industry as 89.16% of the companies are valued more expensively.
1ABBV's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 23.40.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.09 | ||
| Fwd PE | 15.68 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1ABBV indicates a somewhat cheap valuation: 1ABBV is cheaper than 73.49% of the companies listed in the same industry.
Based on the Price/Free Cash Flow ratio, 1ABBV is valued cheaper than 81.93% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 20.46 | ||
| EV/EBITDA | 16.52 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1ABBV does not grow enough to justify the current Price/Earnings ratio.
1ABBV has a very decent profitability rating, which may justify a higher PE ratio.
1ABBV's earnings are expected to grow with 16.75% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.31
PEG (5Y)9.6
EPS Next 2Y19.81%
EPS Next 3Y16.75%
5. Dividend
5.1 Amount
1ABBV has a Yearly Dividend Yield of 3.09%.
1ABBV's Dividend Yield is rather good when compared to the industry average which is at 0.74. 1ABBV pays more dividend than 95.18% of the companies in the same industry.
1ABBV's Dividend Yield is rather good when compared to the S&P500 average which is at 2.00.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.09% |
5.2 History
The dividend of 1ABBV is nicely growing with an annual growth rate of 7.72%!
Dividend Growth(5Y)7.72%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
489.69% of the earnings are spent on dividend by 1ABBV. This is not a sustainable payout ratio.
The dividend of 1ABBV is growing, but earnings are growing more, so the dividend growth is sustainable.
DP489.69%
EPS Next 2Y19.81%
EPS Next 3Y16.75%
BIT:1ABBV (12/1/2025, 7:00:00 PM)
194.2
-8.8 (-4.33%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners74.96%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap343.23B
Revenue(TTM)59.64B
Net Income(TTM)2.35B
Analysts77.89
Price Target213.47 (9.92%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.09% |
Yearly Dividend5.32
Dividend Growth(5Y)7.72%
DP489.69%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.85%
Min EPS beat(2)0.95%
Max EPS beat(2)2.75%
EPS beat(4)4
Avg EPS beat(4)1.21%
Min EPS beat(4)0.02%
Max EPS beat(4)2.75%
EPS beat(8)7
Avg EPS beat(8)0.95%
EPS beat(12)9
Avg EPS beat(12)0.65%
EPS beat(16)11
Avg EPS beat(16)0.49%
Revenue beat(2)1
Avg Revenue beat(2)-0.08%
Min Revenue beat(2)-0.79%
Max Revenue beat(2)0.63%
Revenue beat(4)2
Avg Revenue beat(4)0.22%
Min Revenue beat(4)-0.79%
Max Revenue beat(4)1.23%
Revenue beat(8)4
Avg Revenue beat(8)0.31%
Revenue beat(12)5
Avg Revenue beat(12)-0.17%
Revenue beat(16)5
Avg Revenue beat(16)-0.74%
PT rev (1m)7.91%
PT rev (3m)13.23%
EPS NQ rev (1m)0.85%
EPS NQ rev (3m)0.63%
EPS NY rev (1m)1.03%
EPS NY rev (3m)-11.53%
Revenue NQ rev (1m)0.47%
Revenue NQ rev (3m)0.52%
Revenue NY rev (1m)0.46%
Revenue NY rev (3m)0.46%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.09 | ||
| Fwd PE | 15.68 | ||
| P/S | 6.75 | ||
| P/FCF | 20.46 | ||
| P/OCF | 19.3 | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | 16.52 |
EPS(TTM)8.06
EY4.15%
EPS(NY)12.38
Fwd EY6.38%
FCF(TTM)9.49
FCFY4.89%
OCF(TTM)10.06
OCFY5.18%
SpS28.77
BVpS-1.27
TBVpS-44.65
PEG (NY)3.31
PEG (5Y)9.6
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.75% | ||
| ROE | N/A | ||
| ROCE | 20.86% | ||
| ROIC | 15.64% | ||
| ROICexc | 16.59% | ||
| ROICexgc | 572.43% | ||
| OM | 33.05% | ||
| PM (TTM) | 3.94% | ||
| GM | 71.16% | ||
| FCFM | 33% |
ROA(3y)5.07%
ROA(5y)5.21%
ROE(3y)80.76%
ROE(5y)70.31%
ROIC(3y)13.67%
ROIC(5y)12.68%
ROICexc(3y)15.06%
ROICexc(5y)13.91%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)17.54%
ROCE(5y)16.27%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y-1.81%
ROICexc growth 5Y-14.87%
OM growth 3Y-5.46%
OM growth 5Y-6.52%
PM growth 3Y-28.3%
PM growth 5Y-20.42%
GM growth 3Y0.39%
GM growth 5Y-1.92%
F-Score7
Asset Turnover0.45
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | 3.49 | ||
| Debt/EBITDA | 2.39 | ||
| Cap/Depr | 14.25% | ||
| Cap/Sales | 1.97% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 74.59% | ||
| Profit Quality | 838.33% | ||
| Current Ratio | 0.72 | ||
| Quick Ratio | 0.6 | ||
| Altman-Z | 2.45 |
F-Score7
WACC8.33%
ROIC/WACC1.88
Cap/Depr(3y)9.59%
Cap/Depr(5y)10.06%
Cap/Sales(3y)1.45%
Cap/Sales(5y)1.5%
Profit Quality(3y)361.43%
Profit Quality(5y)328.91%
High Growth Momentum
Growth
EPS 1Y (TTM)-12.09%
EPS 3Y-7.24%
EPS 5Y2.51%
EPS Q2Q%-38%
EPS Next Y7.28%
EPS Next 2Y19.81%
EPS Next 3Y16.75%
EPS Next 5Y13.69%
Revenue 1Y (TTM)7.4%
Revenue growth 3Y0.08%
Revenue growth 5Y11.11%
Sales Q2Q%9.1%
Revenue Next Year8.73%
Revenue Next 2Y9.07%
Revenue Next 3Y8.57%
Revenue Next 5Y7.42%
EBIT growth 1Y27.38%
EBIT growth 3Y-5.38%
EBIT growth 5Y3.87%
EBIT Next Year9.29%
EBIT Next 3Y15.46%
EBIT Next 5Y11.36%
FCF growth 1Y-20.4%
FCF growth 3Y-6.75%
FCF growth 5Y6.9%
OCF growth 1Y-18.24%
OCF growth 3Y-6.19%
OCF growth 5Y7.14%
ABBVIE INC / 1ABBV.MI FAQ
Can you provide the ChartMill fundamental rating for ABBVIE INC?
ChartMill assigns a fundamental rating of 5 / 10 to 1ABBV.MI.
Can you provide the valuation status for ABBVIE INC?
ChartMill assigns a valuation rating of 5 / 10 to ABBVIE INC (1ABBV.MI). This can be considered as Fairly Valued.
What is the profitability of 1ABBV stock?
ABBVIE INC (1ABBV.MI) has a profitability rating of 6 / 10.
Can you provide the PE and PB ratios for 1ABBV stock?
The Price/Earnings (PE) ratio for ABBVIE INC (1ABBV.MI) is 24.09 and the Price/Book (PB) ratio is -152.4.
Can you provide the financial health for 1ABBV stock?
The financial health rating of ABBVIE INC (1ABBV.MI) is 3 / 10.